BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26984746)

  • 1. Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
    Cordova JS; Shu HK; Liang Z; Gurbani SS; Cooper LA; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG; Hadjipanayis CG; Shim H
    Neuro Oncol; 2016 Aug; 18(8):1180-9. PubMed ID: 26984746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow.
    Gurbani S; Weinberg B; Cooper L; Mellon E; Schreibmann E; Sheriff S; Maudsley A; Goryawala M; Shu HK; Shim H
    Tomography; 2019 Mar; 5(1):184-191. PubMed ID: 30854456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.
    Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 8. Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.
    Cordova JS; Kandula S; Gurbani S; Zhong J; Tejani M; Kayode O; Patel K; Prabhu R; Schreibmann E; Crocker I; Holder CA; Shim H; Shu HK
    Tomography; 2016 Dec; 2(4):366-373. PubMed ID: 28105468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
    J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.
    Parra NA; Maudsley AA; Gupta RK; Ishkanian F; Huang K; Walker GR; Padgett K; Roy B; Panoff J; Markoe A; Stoyanova R
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):376-84. PubMed ID: 25066215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral Radiance of Protoporphyrin IX Fluorescence and Its Histopathological Implications in 5-Aminolevulinic Acid-Guided Surgery for Glioblastoma.
    Yoneda T; Nonoguchi N; Ikeda N; Yagi R; Kawabata S; Furuse M; Hirose Y; Kuwabara H; Tamura Y; Kajimoto Y; Kuroiwa T
    Photomed Laser Surg; 2018 May; 36(5):266-272. PubMed ID: 29480754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
    Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
    Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Fluorescence-Guided Resection Increases Radicality in Glioblastoma Surgery.
    Bettag C; Hussein A; Behme D; Maragkou T; Rohde V; Mielke D
    Oper Neurosurg (Hagerstown); 2020 Jan; 18(1):41-46. PubMed ID: 31058980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
    Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
    Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
    Ganslandt O; Stadlbauer A; Fahlbusch R; Kamada K; Buslei R; Blumcke I; Moser E; Nimsky C
    Neurosurgery; 2005 Apr; 56(2 Suppl):291-8; discussion 291-8. PubMed ID: 15794826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.